Envoy Medical (COCH) Raw Materials (2022 - 2026)

Envoy Medical has disclosed Raw Materials across 5 years of filings, most recently posting $1.2 million for Q1 2026.

• Raw Materials for Q1 2026 came in at $1.2 million, down 13.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 13.55% YoY), and the FY2025 annual result was $1.3 million, down 8.95% from the prior year.
• Raw Materials came in at $1.2 million for Q1 2026 at Envoy Medical, down from $1.3 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.4 million in Q1 2025 to a low of $1.0 million in Q4 2022.
• The 5-year median for Raw Materials is $1.3 million (2024), against an average of $1.3 million.
• Across the five-year window, Raw Materials grew 19.28% in 2024 and dropped 13.55% in 2026, its largest moves.
• Envoy Medical's Raw Materials stood at $1.0 million in 2022, then grew by 15.05% to $1.2 million in 2023, then gained by 19.28% to $1.4 million in 2024, then dropped by 8.95% to $1.3 million in 2025, then decreased by 1.43% to $1.2 million in 2026.
• The last three Raw Materials figures came in at $1.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.